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Abstract The Rnd proteins constitute an exceptional subfamily
within the Rho GTPase family. They possess extended chains at
both termini and four prominent amino acid deviations causing
GTPase de¢ciency. Herein, we report the crystal structure of
the Rnd3/RhoE G-domain (amino acids 19^200) at 2.0 A+ reso-
lution. This is the ¢rst GTP-structure of a Rho family member
which reveals a similar fold but striking di¡erences from RhoA
concerning (i) GTPase center, (ii) charge distribution at several
surface areas, (iii) C3-transferase binding site and (iv) interact-
ing interfaces towards RhoA regulators and e¡ectors. / 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
The guanine nucleotide-binding proteins of the Rho sub-
family control a large variety of biological processes, many
of which are associated with dynamic cytoskeletal reorganiza-
tion [1]. These proteins act as molecular switches cycling be-
tween two conformational states, the inactive GDP-bound
and the active GTP-bound state. The cycling rate is controlled
by two biochemically di¡erent reactions, the GDP/GTP ex-
change and the GTP-hydrolysis (GTPase reaction). These in-
trinsically very slow reactions can be accelerated dramatically
by guanine nucleotide exchange factors (GEFs) of the Dbl
family and GTPase activating proteins (GAPs) [1,2]. The ac-
tivated Rho proteins subsequently bind to their downstream
e¡ectors mediating the cellular response [3]. The signalling
pathway is switched o¡ via GAP-dependent stimulation of
the GTP-hydrolysis reaction of the Rho proteins [2]. An addi-
tional level of regulation is provided by guanine nucleotide
dissociation inhibitors (GDIs) that spatially dislodge the
Rho proteins from their subcellular membrane localization [4].
Recently, the GTP-binding proteins of the Rnd subfamily
(Rnd1/Rho6, Rnd2/Rho7 and Rnd3/RhoE/Rho8) have been
described as novel and unusual members of the Rho family
that display substantial structural di¡erences compared to the
classical molecular switches [5] : (i) they have a N-terminal
(2^18 residues) and a C-terminal (about 30 residues) extension
compared to Rho proteins; (ii) unlike most other Rho pro-
teins that are geranylgeranylated, Rnd3 is farnesylated at the
C-terminus (CAAX box). The CAAX box is required for
proper membrane localization; (iii) most remarkably, these
proteins harbor amino acid deviations at codons 12, 13, 59
and 61 (Ras numbering) [6]. Mutation of the respective co-
dons in Ras genes are found in 40% of human tumors and are
responsible for the Ras-mediated malignant transformation
[7]. Impaired GTPase activity, particularly in the presence of
RasGAPs, has been found to be the biochemical reason be-
hind the oncogenicity of Ras [8]. Accordingly, Rnd proteins
may exist merely in the GTP-bound conformation since they
are unable to hydrolyze GTP and ^in addition^ resistant to-
wards GAP activity [6,9,10].
It is currently believed that Rnd proteins antagonize some
e¡ects of the RhoA-induced cytoskeletal reorganization, due
to the following observations: (i) transient expression of Rnd1
and Rnd3 inhibit the assembly of actin stress ¢bers and the
formation of integrin-based focal adhesions in ¢broblasts and
MDCK cells, respectively [9,10]. These rearrangements of the
actin cytoskeleton are regulated cooperatively by two RhoA
downstream e¡ectors, ROCK and mDia [11] ; (ii) in MDCK
cells, the activation of the RAF^MEK^ERK kinase cascade
induces Rnd3 expression leading to loss of actin stress ¢bers
[12] ; (iii) contrary to the e¡ect of RhoA activation, Rnd3
promotes scatter factor-stimulated MDCK cell migration
[10] ; (iv) Xenopus Rnd1 (XRnd1) disrupts cell adhesion in
early embryogenesis which can be fully restored by a consti-
tutively active RhoA mutant [13]. It is therefore implicated
that Rnd proteins may interfere with the Rho activation or
with RhoA downstream signalling by binding and sequester-
ing either of these proteins [9,10].
Here, we present the crystal structure of the Rnd3 G-do-
main (amino acids 19^200) at high resolution (2.0 AG ). A de-
tailed comparison between the Rnd3 and RhoA structures
provides insights into distinct structural di¡erences implicat-
ing a di¡erent intermolecular speci¢city.
2. Materials, methods, molecular replacement and
crystallographic re¢nement
The G-domain of Rnd3 (19^200) was isolated as glutathione
S-transferase fusion protein and puri¢ed after cleavage with thrombin
by size exclusion chromatography (Superdex G75, Pharmacia, Frei-
burg, Germany). The concentration of the bound nucleotide and GTP
hydrolysis were analyzed by reversed-phase high-performance liquid
chromatography as described [14]. Due to degradation of the full
length protein the G-domain was chosen for crystallization.
Crystals were grown at 20‡C using the hanging-drop method by
mixing 2 Wl of a 1 mM solution of the Rnd3 G-domain in 20 mM
0014-5793 / 02 / $22.00 J 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 2 ) 0 3 0 9 4 - 6
*Corresponding author. Fax: (49)-231-1332199.
E-mail address: reza.ahmadian@mpi-dortmund.mpg.de
(M.R. Ahmadian).
1 The atomic coordinates and structure factors (code 1M7B) have
been deposited in the Protein Data Bank
FEBS 26352 2-8-02 Cyaan Magenta Geel Zwart
FEBS 26352FEBS Letters 525 (2002) 100^104
Tris/HCl pH 7.5, 2 mM MgCl2, 2 mM DTE with 2 Wl reservoir so-
lution consisting of 100 mM sodium acetate bu¡er pH 4.6 and 8%
PEG4000. X-ray di¡raction data was collected at room temperature
with a MAR 345 Image Plate System detector (X-Ray Research
GmbH, Norderstedt, Germany) using focused X-rays from a FR591
rotating-CuKK-anode generator (Enraf Nonius, Delft, The Nether-
lands) equipped with osmic mirrors (X-Ray Research GmbH, Nor-
derstedt). Data reduction and processing were done using the DEN-
ZO/SCALEPACK program package [15] (Table 1). The crystal
di¡racted up to 2.0 AG resolution and belonged to space group I222
(a=63.592, b=69.932, c=97.715), with one molecule in the asymmet-
ric unit.
The structure of the GTP-bound Rnd3 G-domain was solved by
molecular replacement with the program AMoRe (Table 1) [16]. For
this purpose the RhoA(G14V)WGTPQS structure (PDB code 1A2B)
was employed as a search model [17]. After 20 rounds of model
building using the program O and simulated annealing re¢nement
with CNS the crystallographic R value was 20.1% (free R value of
4.3%)[18,19]. The ¢nal model includes 179 residues of Rnd3, one GTP
molecule, one magnesium ion and 48 water molecules. The N-terminal
residues Gly-Ser-Asn-Gln-Asn (Gly-Ser due to the thrombin cleavage
site) could not be observed in the electron density map. The residues
22^23 (Val^Lys) and 200 (Lys) are included as alanines in the model.
3. Results and discussion
3.1. Overall fold and nucleotide binding
A ribbon plot in Fig. 1 showing the secondary structure
elements of the Rnd3 structure is superimposed onto the
GTPQS-bound Rho(G14V) model [17]. The main features con-
sisting of a six-stranded L-sheet (¢ve parallel and one antipar-
allel) surrounded by ¢ve K-helices connected by loops and one
insert helix are conserved, as found in Cdc42, Rac and RhoA
proteins (Figs. 1 and 2A) [17,20^23]. The obvious minor dif-
ferences between both structures correspond to the low root
mean square deviation (r.m.s.d.) of 0.79 AG for 177 common
CK-atoms. A large number of polar and non-polar interac-
tions dictating the guanine nucleotide binding in small
GTPases are mostly conserved in Rnd3 too. However, the
GTP-binding site of Rnd3 reveals two remarkable di¡erences
in the GTP coordination as compared to RhoA. The ¢rst
di¡erence is an additional water molecule in Rnd3 which con-
tacts the invariant Ala179 of the 177CSAL-motif and the car-
bonyl oxygen of the base. The second di¡erence is the addi-
tional stabilization of the invariant Lys136 of the 135CKSD-
motif by Asp103 which is Ser85 in RhoA.
3.2. Defective GTPase center
It has been shown before by several groups that Rnd pro-
teins are unable to hydrolyze GTP and ^in addition^ are re-
sistant towards GAP activity [6,9,10]. The G-domain of Rnd3
is also completely disabled to hydrolyze GTP in the absence
and in the presence of p50RhoGAP (data not shown). Four
amino acid deviations are responsible for the Rnd3 GTPase
de¢ciency: Ser32 (Gly14 in Rho), Gln33 (Ala15), Ser79
(Ala61) and Ser81 (Gln63) (Fig. 2A). Mutations of the respec-
tive codons in ras genes (Gly12, Gly13, Ala59 and Gln61),
found in human tumors are responsible for Ras-mediated
malignant transformation [7]. The structural status of the
four deviating residues in Rnd3 are highlighted in Fig. 2B.
The side chain of Ser81, which corresponds to the catalytically
active Gln63 in RhoA, is rotated away from the Q-phosphate
and is unable to stabilize a nucleophilic water molecule for an
in-line attack of the Q-phosphate [17]. The position of the
Q-phosphate is not changed in Rnd3 but two water molecules
close to the Q-phosphate which are coordinated by Ser32,
Ser79 and by the conserved Gly80, respectively, are in a di¡er-
ent position compared to RhoA (Fig. 2B). The side chain of
Ser32, on the other hand, would sterically interfere with the
arginine ¢nger of RhoGAP [8,24]. In conclusion, all require-
ments for a functional GTPase machinery are missing which
suggests that Rnd3 exists only in the GTP-bound form and
that Rnd proteins may not be regulated by the conventional
cycling mechanism.
3.3. Surface areas
Signal transduction pathways are induced or inhibited
through speci¢c protein^protein interactions that often pro-
vide well de¢ned interfaces concerning shape and electrostatic
complementarity [25]. The solvent accessible surface area of
Table 1
Data collection and re¢nement statistics of Rnd3
Intensity data processing
Resolution 2.0 AG
Number of measurements 48439
Number of independent re£ections 14843
Rsyma 9.2 (32.5)b
Completeness 98.6 (98.2)b
Mean GI/c(I)f 8.4 (1.5)b
Molecular replacement statistics
Resolution range rotation/translation 12.0^5.0 AG /8.0^4.0 AG
Rotationc 9.6, 73.17, 267.46
Translationc 39.48, 35.39, 30.04
Correlation coe⁄cient 59.8 (31.8)d
Rcryste 39.0 (48.8)d
Re¢nement statistics
Rcryste 20.1
Rfreee 24.3
R.m.s. bond lengths 0.006
R.m.s. bond angles 1.2
aRsym = 100W4MI3GIfM/4I.
bIn parenthesis are quantities calculated in the highest resolution
bin at 2.07^2.0 AG .
cEulerian angles (K,L,Q) are as de¢ned in AMoRe and translations
in the orthogonal system.
dIn parenthesis are quantities of the second-best solution.
eRcryst = 100W4MFo3FcM=4Fo. Rfree is Rcryst that was calculated using
10% of the data, chosen randomly, and omitted from the subse-
quent structure re¢nement.
Fig. 1. Rnd3 Structure. Ribbon representation of Rnd3WGTP (green)
compared with RhoA(G12V)WGTPQS (grey) [17] were analyzed by
the program DSSP [40] and drawn using the program Bobscript
[41,42]. Structural comparison of Rnd3 and RhoA was carried out
with the least squares option of the program O [18]. P-loop, switch
I, switch II and insert-helix are highlighted in orange.
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both Rnd3 and RhoA structures exhibits major di¡erences
which are mainly due to low sequence homology (43% identity
for the G-domain, Figs. 2A and 3A). Rnd3 shows a higher
density of non-polar residues most notably at the regions of
the L2^L3-strands, the insert- and K5-helices. The L2-strand of
Rnd3, for instance, forms a hydrophobic groove which is
£anked by alternating positive and negative charges. Interest-
ingly, the switch regions show only minor changes concerning
the shape (Fig. 3A) and nearly no di¡erences concerning the
electrostatic potentials (not shown).
3.4. Interacting interfaces
The proposed Rnd3 antagonism with RhoA for common
interacting partners presumes that Rnd3 reproduces essential
structural features of RhoA to bind and sequester RhoA reg-
ulators or e¡ectors. In order to prove such a structural mimi-
cry we analyzed the interfaces of RhoA interacting with ADP-
ribosylation enzymes, GDIs, GAPs, GEFs and e¡ectors, and
compared them with the corresponding surface areas of Rnd3
(Fig. 3B).
3.4.1. ADP-ribosylation. The biological activities of Rho
GTPases can be blocked by C3-like transferases from Clostri-
dium botulinum (C3Bot), which ADP-ribosylate RhoA (at
Asn41), but not Rnd3 [26]. A novel C3-like exoenzyme from
Staphylococcus aureus (C3Stau) has been reported to modify
e⁄ciently RhoA at Asn41 and with a slower velocity also
Rnd3 at the corresponding Asn59 [27]. From the structural
and biochemical data, a hydrophobic patch on the surface of
RhoA formed by Val38, Phe39, Val43, Trp58 and Leu72 has
been proposed to bind the C3 exoenzymes (Fig. 3B)
[26,28,29]. Thr61 and Ser74 in Rnd3 that are di¡erent com-
pared to Val43 and Ala56 (which is close to the patch) in
RhoA, may a¡ect the interaction between the C3-transferase
and Rnd3. Furthermore, the side chains of the asparagines 59
and 41 of Rnd3 and RhoA exhibit a di¡erent orientation (Fig.
3B). Unlike RhoA where Asn41 is exposed to the solvent,
Asn59 in Rnd3 is locked in a more restricted and less acces-
sible conformation due to its interaction with Ser74 (Ala56 in
RhoA; Fig. 3B). Thus, we propose that both the divergence in
the hydrophobic patch and the di¡erent coordination of
Asn59 may cause the di¡erent modi¢cation rates.
3.4.2. RhoGDI-binding. From four di¡erent crystal struc-
tures it is known that GDI-binding utilizes the switch I/II, the
adjacent K3-helix and the geranylgeranyl moiety [30^33]. The
GDI-domain interacting interface of RhoA is predominantly
conserved in Rnd3 except for Asn86 and Glu123 (Arg68 and
His105 in RhoA; Fig. 3B). The particular role of Arg68 and
His105 is to bind the C-terminal domain of GDI and stabilize
its interaction with the N-terminal GDI-domain. The C-ter-
minal domain subsequently binds to the geranylgeranyl moi-
ety of the Rho proteins leading to membrane release [31,32].
We propose that the N-terminal regulatory domain of RhoG-
DI may bind to Rnd3 but any cellular GDI activity on Rnd3
remains unlikely because Asn86 and Glu123 in Rnd3 may
electrostatically clash with the C-terminal domain of the
GDI. In addition, it has been shown recently that RhoGDI
indeed does not extract Rnd3 from the membrane [34].
3.4.3. RhoGAP-binding. As described above, the GTPase
reaction of Rnd3 is resistant towards RhoGAP activation
because of the absence of a catalytically competent glutamine
(Ser81 in Rnd3) and the sterical clash of the arginine ¢nger
(RhoGAP) with Ser32 (Rnd3). It has been shown that the
Fig. 2. Rnd proteins and GTP-binding. A: Sequence alignment of the Rnd proteins was performed using the program GeneDoc [44]. Invariant
amino acids are boxed and identical residues in three proteins are red. Structural motives characteristic for small GTPases are indicated by
dark boxes: P-loop, switch I, switch II and Rho-insert region. The assignment for Rnd3 is based on the ¢nal re¢ned model (Table 1). Amino
acids marked by asterisks indicate special residues discussed in the text. B: GTPase-de¢cient center. Stereo-view of the ¢nal 2Fo3Fc omit elec-
tron density map around the nucleotide-binding site of Rnd3 and RhoA (blue) drawn with Bobscript [42]. The map was calculated with the
¢nal re¢ned atomic model by simulated annealing after the removal of the Mg2þ ion and the GTP. The Rnd3 residues and water molecules
(orange) are highlighted.
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Gly12 (to Val) mutant of Ras still binds to RasGAP with
similar a⁄nity compared to wild-type but without subsequent
stimulation of the GTPase reaction [35,36]. It is known that
the RhoA^RhoGAP interaction is mediated through the
switch regions and to a lower extent through the P-loop and
K3-helix [24]. Four of the six residues of RhoA that are in-
volved in an extensive hydrogen-bonding network with Rho-
GAP deviate in Rnd3 (Figs. 2A and 3B). Most interestingly,
the corresponding residue to Asp65 of RhoA, which contacts
Lys122 and Arg126 of RhoGAP and stabilize the RhoA
switch II region, is Tyr83 in Rnd3. This may cause a sterical
clash between Rnd3 and RhoGAP. These structural di¡eren-
ces and the fact that the binding a⁄nity of diverse RhoGAPs
for RhoA is very low (between 2 and 90 WM) [37], make a
Rnd3^RhoGAP interaction unlikely.
3.4.4. RhoGEF-binding. Since the Rnd proteins do not hy-
drolyze GTP and are resistant towards GAP activity, and
since the physiological GTP concentration in the cell is 10-
fold higher than that for GDP, we presume that these Rho-
related proteins are not subjected to any GEF-mediated acti-
vation. However, it has also been suggested that the e¡ect of
Rnd proteins on Rho signalling might arise from their inter-
ference with the upstream signals leading to Rho activation
[9]. Thus, we would like to address the question whether Rnd3
may bind and sequester RhoGEFs. Presently, no RhoA^Rho-
GEF structure is available but fortunately the structure of
Cdc42 in complex with the DH/PH fragment of Dbs is known
which also e⁄ciently activates the nucleotide exchange reac-
tion of RhoA [38]. The vast majority of Dbs-binding residues
of the Cdc42 switch regions and K3-helix are not only con-
served in RhoA but also in Rnd3. The only deviations are
Arg68 and His105 which correspond to Asn86 and Glu123 in
Rnd3, respectively (Fig. 3B). Interestingly, Arg66 and His103
of Cdc42 form a hydrogen-bonding network with the Dbs
PH-domain [38]. Accordingly, we suggest that Rnd3 may
bind the DH- but not the PH-domain as shown for the
Cdc42WDbs complex.
3.4.5. E¡ector binding. The most fundamental protein^
protein interaction in signal transduction is the speci¢c and
selective interaction of the GTP-binding proteins with various
downstream e¡ectors [3]. It is known from the crystal struc-
ture of RhoA^PKN that the N-terminus of PKN binds three
regions of RhoA, the switch I, L2/L3-strands and K5-helix
[39]. Eight of the 17 residues of RhoA interacting with
PKN, are not conserved in Rnd3 (Figs. 1, 2 and 3B). This
and the di¡erences at the PKN-binding surface area argue
against a Rnd3 interaction with PKN and PKN-related pro-
teins Rhotekin and Rhophilin. Unfortunately, we cannot pre-
dict any Rnd3 interaction with ROCK and mDia since there
is no structural data available. These e¡ectors which are me-
diators of the Rho-induced formation of stress ¢ber and focal
adhesion, however, would be the appropriate targets for the
Rnd proteins concerning their antagonistic e¡ects on RhoA.
4. Conclusions
Despite a high structural homology, the GTP structure of
Rnd3 revealed signi¢cant di¡erences compared to the GTPQS
structure of RhoA. Both proteins show remarkable di¡erences
at certain surface areas responsible for the interaction of
RhoA with its interacting partners. Conventional mechanisms
(GDI, GAP and GEF) known for most small GTPases may
not be utilized to regulate Rnd3 activity. A Rnd3 interaction
with Rho e¡ectors such as PKN, Rhophilin and Rhotekin is
quite unlikely, but no statement regarding ROCK, mDia and
Citron interaction with Rnd3 is possible, yet, because they are
structurally poorly investigated. Rnd proteins are expressed in
diverse tissues. Whereas Rnd3 is ubiquitously expressed at a
low basic level, Rnd1 and Rnd2 are expressed in brain and
testis, respectively [6]. This di¡erent expression pattern and
the high sequence homology between the G-domains (almost
90%) support the notion that the Rnd proteins may recruit
similar interacting partners. Important questions as how the
cellular activities of the Rnd proteins are regulated and
Fig. 3. Comparison of the surface and interacting areas of Rnd3 and RhoA. A: Surface deviations. Rnd3 (left panel) and RhoA (right panel)
in the same orientation (upper panel) as in Fig. 1 and the back view (180‡ rotation around x-axis, lower panel) are presented as GRASP im-
ages [43]. Positively charged amino acids are blue, negatively charged amino acids are red. Surface residues deviating between Rnd3 and RhoA
are marked (single letter code). B: Interacting interfaces of RhoA. Residues of RhoA involved in binding of RhoGDI (green), p50RhoGAP
(blue), PKN (pink) and C3-transferases (orange) and the corresponding residues of Rnd3 are highlighted.
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whether they share common downstream targets with RhoA,
however, remain to be answered.
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